Member Info for MisterPositive

Lloyd
No body can put an exact figure on share value until we get an idea of number of tests and number of Biomek i7 in operation through USA.

Hence current future estimates. But revenue numbers from USA alone should be lot more than current Mcap...hence the recent appreciation in price. Market is forward looking approx 6-12 months generally speaking.

Just look at first sign of Vaccine progress last year and DOW and NASDAQ stormed higher way way before we even got a roll out.

Past is already public knowledge. That is why all those suits sitting in Wall Street busy crunching numbers on their financial models calculating forward PE ratios before putting out Buy, Hold, sell ratings.

Punter
Short answer to your question is...I don't know.

We should get more clarity in next RNS confirming GDR and BC distribution deal has gone live in the US and we expect first revenues in the range of x $$$.

We already know FDA has no objection, as stated by GDR. We might get an update on timing of the EUA official approval from FDA next week also or something on those lines.

We also know sales revenues will gradually increase as weekly shipments increase depending on production capacity as its all connected and part of the supply chain.

We can only forecast initial estimates. Actual numbers should come through later depending how GDR announce them, weekly, monthly etc.

In my view Saint T contributes a lot here for the benefit of others. Lot of other respected posters here also with very valuable contributions.

I caught up with lot of info here in double quick time without having to go back to every single RNS having arrived bit late.

Awkward timing with some of the negative rhetoric ahead of a big week !!!

Hmmmm

Some posters are generally more positive and excited than other positive ones. Simple.

Happens across all boards.

US market fully understands the scale of this testing campaign and the profits that would be generated from it for ALL parties involved.

UK market always too pessimistic and too slow in grasping the positive valuation impact.

Market in US obviously very positive about Beckman Coulter testing campaign that is about to start.

Life Sciences & Diagnostics are the biggest profit contributors to Danaher bottom line profit.

Its defo a "multi bagger"

From current £1.5m Mcap....no brainer

2.50

Nice buy Lamb.

You looking to Upgrade your motor too ?

F35
Nice buy sir. Very well timed.

Lol....we can all take turns...

That so called spike would be well in the money when this 10 bags from here.

Just wait for it.

Cannot wait for 15p ;-)

I can then borrow your Ferrari F12 at weekends ;-)

Jdo

Monday RNS and this would open over 2p

I think we are in very good shape here.

Just need any 1 RNS...Senala or Cameroon to really reignite the Boosters here.

Strong shares always go back to re-test previous Highs....so once 200p is cracked..

300p should come lot lot quicker.

Only 63m total shares about ffs

Relax.

You sitting on potential 10 x Bagger.

MCap should be close to £10m
Not £1.5m ???

Close at or above 1.80 takes you to test 3p

If we get any one RNS, then above equation would not even apply as this would just blow the doors off...

Yes. Got to be ahead of the curve.

Still very very cheap. MCap half the revenues?

Its normally other way round.

For £3m revenues, Mcap should be over £10m

Very undervalued.

Yes. I saw few go through @ 1.70 on investing.com